Clinical research site network providing end-to-end Phase I–IV trial services across oncology, CNS, cardiovascular/metabolic, and dermatology. Supports pharma, biotech, and CRO sponsors by accelerating study start-up, enhancing patient access and recruitment, and delivering high-integrity clinical data.